Gabapentin Capsule
Product Images NDC 53746-101

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53746-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

A formula depicting the Cockcroft-Gault equation for estimating creatinine clearance (CLCr). It calculates CLCr based on age, weight, serum creatinine, with an adjustment factor for female patients.*

FDA Label Image

Structural Formula (Gabapentin Capsules Usp 2)

Chemical structure of gabapentin, showing a cyclohexane ring bound to amino (CH2NH2) and carboxylic acid (CH2CO2H) functional groups.*

FDA Label Image

Figure 1 (Gabapentin Capsules Usp 3)

A line graph comparing the mean pain score over 8 weeks between placebo and Gabapentin at 3600 mg/day. The x-axis shows weeks from baseline through 8 weeks, and the y-axis shows the mean pain score from 0 to 10. The graph is divided into a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Gabapentin Capsules Usp 4)

A line graph showing mean pain scores over a 7-week period comparing placebo to Gabapentin at dosages of 1800 mg/day and 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period followed by a 4-week fixed dose period, and the y-axis represents mean pain score values from 0 to 10.*

FDA Label Image

Figure 3 (Gabapentin Capsules Usp 5)

A bar chart comparing percentage values from two studies. Study 1 displays results for PBO and GBP 3600 with percentages of 12% and 29%, respectively. Study 2 shows PBO, GBP 1800, and GBP 2400 with percentages of 14%, 32%, and 34%. Statistical significance markers **p<0.01 and ***p<0.001 are noted above respective bars.*

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

A scatter plot comparing percentage difference by daily dose (mg) for Gabapentin capsules across three studies labeled a, b, and c. The x-axis shows daily doses from 600 to 1800 mg and the y-axis shows difference percentages from 2% to 22%. Data points for each study are displayed with distinct markers and labels at various dose levels.*

FDA Label Image

100 Ct. (Gabapentin Capsules Usp 7)

Label for Gabapentin Capsules, USP 100 mg by Amneal Pharmaceuticals LLC. Contains 30 capsules. The label includes storage instructions, dose information referring to package insert, and pharmacist dispensing guidance. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

FDA Label Image

100 Ct. (Gabapentin Capsules Usp 8)

Label for Gabapentin Capsules, USP, 300 mg strength. The label indicates a package containing 30 capsules and is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Additional text includes storage instructions, pharmacist dispensing guidance, and a barcode.*

FDA Label Image

100 Ct. (Gabapentin Capsules Usp 9)

Gabapentin Capsules, USP 400 mg oral capsules label from Amneal Pharmaceuticals of New York LLC, showing a package count of 30 capsules. The label includes dosage strength, storage instructions, and a small image of an orange capsule with imprint details. The label also states Rx only and includes barcode and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.